Company
Athersys
Overview
Cleveland-based regenerative medicine company developing MultiStem (allogeneic adult stem-cell therapy) for ischemic stroke and ARDS. Listed Chapter 11 in 2024; assets being restructured under Healios partnership.
Company
Cleveland-based regenerative medicine company developing MultiStem (allogeneic adult stem-cell therapy) for ischemic stroke and ARDS. Listed Chapter 11 in 2024; assets being restructured under Healios partnership.